Tamil Nadu AIDS Control Society Staff Face Salary Delays
Approximately 650 counsellors and laboratory technicians working under TANSACS in Tamil Nadu have not received their May salaries. The staff are experiencing financial hardship affecting rent, education, loans, and transportation. This marks a recurring issue, with April salaries also delayed by nearly 10 days.
The Tamil Nadu State AIDS Control Society (TANSACS) has failed to pay salaries to 650 counsellors and laboratory technicians working in Primary Health Centres for the month of May. The Tamil Nadu AIDS Control All Employees Welfare Association has formally appealed to the Chief Minister, Health Minister, and senior officials to address the issue immediately. Staff members are facing significant financial difficulties, including inability to pay house rent, cover children's educational expenses, meet loan installments, and manage transportation costs. This is not an isolated incident; salaries for April were also delayed by approximately 10 days, indicating a pattern of payment delays affecting essential healthcare workers in the state's AIDS control programme.
What's missing
The reasons for the salary delays are not explained in the article. Additionally, there is no information about whether the government has responded to the association's appeal or provided a timeline for payment resolution.
What different sources said
- The HinduCenter
PHC counsellors, laboratory technicians of TANSACS face salary delays
Related
Study Identifies Salivary microRNAs Linked to Long COVID and Periodontal Disease
Researchers analyzed salivary microRNAs in Long COVID patients and found 32 downregulated miRNAs in those with concurrent periodontal disease, suggesting shared inflammatory mechanisms. The study identified specific microRNAs that regulate inflammation pathways and directly target SARS-CoV-2 viral components. These findings suggest salivary microRNAs may serve as biomarkers and therapeutic targets for post-COVID oral complications.
Kennedy Administration's Animal Testing Phase-Out Could Impact Xenotransplantation Research, Critics Warn
Health Secretary Robert F. Kennedy Jr. is pursuing a federal phase-out of animal testing, citing poor predictivity for human health outcomes, with the CDC already transferring primates and NIH halting animal-model-exclusive funding. The shift affects eight NIH-funded primate research centers, with at least one closed and another considering conversion to a sanctuary. The timing concerns researchers who argue xenotransplantation—transplanting animal organs into humans—is approaching clinical breakthroughs that depend on animal studies.
Combination of Pancreatic Cancer Drugs from Tango and Revolution Shows High Response Rate in Early Trial
Tango Therapeutics and Revolution Medicines announced early-stage clinical trial results showing their combination drug therapy produced durable responses in a large majority of pancreatic cancer patients. Revolution's daraxonrasib has recently generated significant attention in oncology for unprecedented outcomes in pancreatic cancer treatment. The results suggest potential for improved therapeutic options in a disease with historically poor prognosis.